Diagnostic Access to Self-Care and Health Services in Low and Middle Income Countries (DASH) - Phase II
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6+
SponsorUniversity of Washington
About this trial
Our primary goal is to determine if on-demand, home-based rapid testing, or rapid testing done by a community health worker (CHW) results in people testing for diseases more frequently and getting care more quickly. These two testing approaches will be compared to how individuals would normally test if they were concerned about certain diseases.
The main questions the study aims to answer are:
* Do either of the testing approaches result in more people testing themselves for certain diseases when needed? * Does self-testing at home or testing done by a community health worker increase the number of individuals receiving test results and getting care/treatment more quickly? * Does at-home screening for high blood pressure and diabetes result in lower blood pressure and hemoglobin A1c levels (an indicator for diabetes)?
Eligibility criteria
Qualifiers
Resides in the household and has spent ≥1 night at the house in the prior four weeks
Plans to reside in the house for duration of the study
Willing and able to provide informed consent, assent, or parental consent (where needed)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Home-based rapid testing
- Community health worker rapid testing
Treatment groups
2,250 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Washington
Lead sponsor
Kenya Medical Research Institute
Collaborator
Centre for Infectious Disease Research in Zambia
Collaborator
Human Sciences Research Council
Collaborator
Bill and Melinda Gates Foundation
Collaborator
Source ClinicalTrials.gov